Dahlöf CG - Search Results

1

Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.

Dahlöf CG, Pascual J, Dodick DW, Dowson AJ. Dahlöf CG, et al. Cephalalgia. 2006 Apr;26(4):400-8. doi: 10.1111/j.1468-2982.2005.01080.x. Cephalalgia. 2006. PMID: 16556240 Review.

2

Almotriptan and zolmitriptan in the acute treatment of migraine.

Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC. Goadsby PJ, et al. Among authors: dahlof cg. Acta Neurol Scand. 2007 Jan;115(1):34-40. doi: 10.1111/j.1600-0404.2006.00739.x. Acta Neurol Scand. 2007. PMID: 17156263 Clinical Trial.

3

How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.

Dahlöf CG, Dodick D, Dowson AJ, Pascual J. Dahlöf CG, et al. Headache. 2002 Feb;42(2):99-113. doi: 10.1046/j.1526-4610.2002.02025.x. Headache. 2002. PMID: 12005302 Review.

4

[Is migraine a progressive cerebral disease?].

Dahlöf CG, Linton-Dahlöf P, Lainez JM, Pascual J. Dahlöf CG, et al. Neurologia. 2005 Sep;20(7):356-65. Neurologia. 2005. PMID: 16163579 Review. Spanish.

5

Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine.

Dahlöf C. Dahlöf C. Cephalalgia. 1993 Jun;13(3):166-71. doi: 10.1046/j.1468-2982.1993.1303166.x. Cephalalgia. 1993. PMID: 8358774 Review.

6

Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine.

Dahlöf C, Björkman R. Dahlöf C, et al. Cephalalgia. 1993 Apr;13(2):117-23. doi: 10.1046/j.1468-2982.1993.1302117.x. Cephalalgia. 1993. PMID: 8495453 Clinical Trial.

7

Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine.

Dowson AJ, Tepper SJ, Dahlöf C. Dowson AJ, et al. J Headache Pain. 2005 Jun;6(3):112-20. doi: 10.1007/s10194-005-0164-3. Epub 2005 May 13. J Headache Pain. 2005. PMID: 16355291 Free PMC article. Review.

8

Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators.

Tfelt-Hansen P, Pascual J, Ramadan N, Dahlöf C, D'Amico D, Diener HC, Hansen JM, Lanteri-Minet M, Loder E, McCrory D, Plancade S, Schwedt T; International Headache Society Clinical Trials Subcommittee. Tfelt-Hansen P, et al. Cephalalgia. 2012 Jan;32(1):6-38. doi: 10.1177/0333102411417901. Cephalalgia. 2012. PMID: 22384463 No abstract available.

9

Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.

Dahlöf CG, Hauge AW, Olesen J. Dahlöf CG, et al. Cephalalgia. 2009 Nov;29 Suppl 2:7-16. doi: 10.1111/j.1468-2982.2009.01975.x. Cephalalgia. 2009. PMID: 19723121 Clinical Trial.

10

Is there a preferred triptan?

Dodick DW, Silberstein S, Dahlöf CG. Dodick DW, et al. Among authors: dahlof cg. Headache. 2002 Jan;42(1):1-7. doi: 10.1046/j.1526-4610.2002.02001.x. Headache. 2002. PMID: 12005269 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters